MTBPROM2.0 has improved agreement between predictions and experimental datasets assessing gene essentiality and overexpression growth defects compared to alternative methods, and it has successfully predicted synergy between TF perturbations and anti-TB drugs. The gene discussed is TF; the disease is tuberculosis.